Genmab A/SGMABNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-21.7%
5Y CAGR-16.6%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-21.7%/yr
vs -2.6%/yr prior
5Y CAGR
-16.6%/yr
Recent deceleration
Acceleration
-19.1pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20253.39+28.9%
20242.63-41.0%
20234.45-36.8%
20227.05-9.0%
20217.75-7.7%
20208.40+26.4%
20196.64-15.2%
20187.83-23.7%
201710.26-29.5%
201614.55-